The Effects of Daridorexant on Patients With Comorbid Insomnia Disorder and Untreated Mild Obstructive Sleep Apnoea: A Post Hoc Subgroup Analysis of a Phase 3, Randomised Clinical Trial

Documenti analoghi

• Excessive Daytime Sleepiness, but Not Insomnia Is Associated With Dyslipidaemia in Patients With Obstructive Sleep Apnoea Participating in ESADA
  di: Andras Bikov, et al.
  Pubblicazione: (2025)
• The Effect of Digital Cognitive Behavioural Therapy for Insomnia in People With Co‐Morbid Insomnia and Sleep Apnoea ( COMISA ): A Pilot Randomised Controlled Trial
  di: Alexander Sweetman, et al.
  Pubblicazione: (2025)
• Management of Insomnia Complaints by Non‐Sleep Specialist Physicians: A French DELPHI Consensus
  di: Pierre‐Alexis Geoffroy, et al.
  Pubblicazione: (2025)
• Validation of Trøndelag Apnoea Score Proxy for Obstructive Sleep Apnoea in the General Population of Norway: The HUNT Study
  di: James Filosa, et al.
  Pubblicazione: (2024)
• Deciphering Insomnia: Benchmarking Automated Sleep Staging Algorithms for Complex Sleep Disorders
  di: Umaer Hanif, et al.
  Pubblicazione: (2025)